Brii Biosciences Limited (BRIBF)
USD 0.13
(0.0%)
USD 0.13
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -174.82 Million CNY | 63.9% |
| 2022 | -484.31 Million CNY | 88.37% |
| 2021 | -4.16 Billion CNY | -250.02% |
| 2020 | -1.18 Billion CNY | -128.32% |
| 2019 | -521.02 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -19.3 Million USD | 0.0% |
| 2024 Q1 | -19.42 Million USD | -1959.33% |
| 2023 Q4 | 2.08 Million USD | 101.97% |
| 2023 FY | -174.82 Million CNY | 63.9% |
| 2023 Q3 | 1.03 Million USD | 103.77% |
| 2023 Q2 | -27.4 Million USD | -98.17% |
| 2023 Q1 | -13.82 Million USD | 29.59% |
| 2022 Q2 | -53.47 Million USD | 0.0% |
| 2022 FY | -484.31 Million CNY | 88.37% |
| 2022 Q4 | -19.63 Million USD | 0.0% |
| 2021 FY | -4.16 Billion CNY | -250.02% |
| 2021 Q4 | -187.89 Million USD | 0.0% |
| 2021 Q2 | -456.3 Million USD | 0.0% |
| 2020 Q2 | -43.88 Million USD | 0.0% |
| 2020 FY | -1.18 Billion CNY | -128.32% |
| 2020 Q4 | -130.06 Million USD | 0.0% |
| 2019 FY | -521.02 Million CNY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -74.96 Million USD | -133.22% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | -2558.547% |
| SQZ Biotechnologies Company | -79.46 Million USD | -120.01% |
| Evofem Biosciences, Inc. | 52.97 Million USD | 429.997% |
| Santhera Pharmaceuticals Holding AG | 65.13 Million USD | 368.419% |
| Mesoblast Limited | -87.95 Million USD | -98.769% |
| Propanc Biopharma, Inc. | -1.82 Million USD | -9503.203% |
| Genus plc | 7.9 Million USD | 2313.025% |
| VioQuest Pharmaceuticals, Inc. | -10.89 Million USD | -1505.152% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | -4612.075% |
| Marizyme, Inc. | -65.34 Million USD | -167.54% |
| ContraFect Corporation | -65.15 Million USD | -168.336% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | -1876.809% |
| PsyBio Therapeutics Corp. | -4.88 Million USD | -3478.116% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | -10020.611% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | -5944.439% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | -2069.18% |
| MultiCell Technologies, Inc. | -380.07 USD | -45999058.05% |
| Accustem Sciences Inc. | -3.74 Million USD | -4566.563% |
| RVL Pharmaceuticals plc | -51.69 Million USD | -238.213% |
| EV Biologics, Inc. | -1.26 Million USD | -13697.199% |
| Q BioMed Inc. | -2.05 Million USD | -8419.546% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | -4583.338% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -27545.013% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | -7243.072% |
| Biomind Labs Inc. | -1.21 Million USD | -14297.288% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | -10.54 Million USD | -1557.461% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | -2112.159% |
| Skye Bioscience, Inc. | -37.64 Million USD | -364.418% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | -7957.327% |
| THC Farmaceuticals, Inc. | -14.97 Thousand USD | -1167294.498% |
| Arch Therapeutics, Inc. | -6.98 Million USD | -2403.696% |
| IMV Inc. | -36.48 Million USD | -379.171% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | -1001.532% |
| Curative Biotechnology, Inc. | -5.81 Million USD | -2905.353% |
| GB Sciences, Inc. | -1.36 Million USD | -12739.242% |
| Alpha Cognition Inc. | -13.77 Million USD | -1169.4% |
| HST Global, Inc. | -146.21 Thousand USD | -119473.901% |
| CSL Limited | 2.64 Billion USD | 106.617% |
| Halberd Corporation | -79.67 Thousand USD | -219324.921% |
| Enzolytics Inc. | -2.17 Million USD | -7931.35% |
| Resverlogix Corp. | -3.61 Million USD | -4742.909% |
| Affymax, Inc. | -14.42 Million USD | -1112.07% |
| SYBLEU INC | -180.3 Thousand USD | -96863.462% |
| Nuo Therapeutics, Inc. | -3.17 Million USD | -5412.613% |
| argenx SE | -295.05 Million USD | 40.747% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | -179.284% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | 178496.939% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | -4300.436% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | -5677.303% |
| AVAX Technologies, Inc. | -6.41 Million USD | -2625.89% |
| Zenith Capital Corp. | -10.59 Million USD | -1549.953% |
| Genscript Biotech Corporation | -95.47 Million USD | -83.111% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | -752111.514% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | -4116.876% |
| WPD Pharmaceuticals Inc. | -60.44 Thousand USD | -289157.504% |
| American Oriental Bioengineering, Inc. | -59.72 Million USD | -192.721% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | -5536.431% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -1.05 Million USD | -16454.883% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | -8869.044% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -3.81 Million USD | -4477.874% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -8619.151% |
| BioStem Technologies, Inc. | -8.48 Million USD | -1960.938% |
| ONE Bio Corp. | 8.67 Million USD | 2114.945% |
| Reve Technologies, Inc. | -441.36 Thousand USD | -39510.621% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -12991.579% |
| Wesana Health Holdings Inc. | -1.75 Million USD | -9863.066% |
| Agentix Corp. | -1.37 Million USD | -12622.137% |
| LadRx Corporation | 400.44 Thousand USD | 43758.898% |
| Cell Source, Inc. | -5.32 Million USD | -3185.511% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -41978.902% |
| Regen BioPharma, Inc. | 1.02 Million USD | 17181.352% |
| Regen BioPharma, Inc. | 1.02 Million USD | 17181.352% |
| NovAccess Global Inc. | -4.76 Million USD | -3565.803% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | 2624.755% |
| Itoco Inc. | -1.86 Million USD | -9254.172% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | -3835.343% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | -10375.075% |
| Kadimastem Ltd | -3.3 Million USD | -5185.998% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | -63845.765% |
| CytoDyn Inc. | -49.84 Million USD | -250.773% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | -221110.127% |
| Mobile Lads Corp. | -2.26 Million USD | -7624.545% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | -76536.698% |
| Qrons Inc. | -789.34 Thousand USD | -22048.561% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | -18468.626% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -2.08 Million USD | -8274.312% |
| Rebus Holdings, Inc. | -1.02 Million USD | -17040.098% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | -10740.515% |
| International Stem Cell Corporation | -131 Thousand USD | -133357.252% |
| Bioxytran, Inc. | -4.28 Million USD | -3984.788% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | -322034.802% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | -6809.563% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -48.07 Million USD | -263.682% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | -8170.057% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -780.88 Thousand USD | -22288.515% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | -5418.592% |
| Neutra Corp. | -233.46 Thousand USD | -74784.458% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -761.609% |
| PureTech Health plc | -65.69 Million USD | -166.114% |
| Coeptis Therapeutics, Inc. | -21.26 Million USD | -722.085% |
| IXICO plc | -1.17 Million USD | -14741.171% |
| IntelGenx Technologies Corp. | -9.92 Million USD | -1661.146% |
| Gelesis Holdings, Inc. | -57.12 Million USD | -206.03% |
| CSL Limited | 2.64 Billion USD | 106.617% |
| Cellectis S.A. | -103.17 Million USD | -69.451% |